What is the future of cancer research in terms of these biomolecules?
The future of cancer research is moving towards a more integrated approach that considers the interplay between lipids, proteins, and DNA. Advances in technologies like next-generation sequencing, mass spectrometry, and bioinformatics are enabling a more comprehensive understanding of the molecular alterations in cancer. Personalized medicine, based on the specific lipid, protein, and genetic profiles of an individual's tumor, holds the promise of more effective and less toxic treatments. Immunotherapy, which harnesses the body's immune system to target cancer cells, is also being combined with lipid, protein, and DNA-targeted therapies to improve outcomes.
